Grants / Agency for International Development / Agency for International Development

7200AA24RFA00001: Ending Neglected Diseases through Operational Research (ENDOR)

Closed Closed December 8, 2023 Opportunity 7200AA24RFA00001 ☆ Save

This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Agency for International Development notices from 2023.

• Award ceiling$45.0 million
• Total funding$45.0 million
• Expected awards1
• Cost sharingNot required
• Funding typeCooperative Agreement

Key dates

Who can apply

This opportunity was open to any type of organization.

• Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses, individuals.

Is this a realistic fit?

• Past USAID Foreign Assistance for Programs Overseas awards averaged $8.7 million; this notice allows up to $45.0 million per award.
• Most of the program's money (54% over five years) went to nonprofits.
• No cost sharing or match is required.

What the grant funds

Project Title: Ending Neglected Diseases through Operational Research (ENDOR) Subject: Notice of Funding Opportunity (NOFO) Number: 7200AA24RFA00001 Deadline for Question/Clarifications: November 6, 2023; 1:00PM, Washington, DC Time Closing Date: December 8, 2023 Closing Time: 1:00PM, Washington, DC Time Under this five-year cooperative agreement, USAID intends to transfer federal Global Health (GH) assistance funds by awarding one cooperative agreement to an organization or to a consortium of organizations. WHO’s 2030 NTD Roadmap Gap Assessment, and recent WHO NTD Global Partners Meeting, highlight several gaps in disease-specific strategies for mapping, monitoring and evaluation, availability of accurate and field-friendly diagnostics, and sustainable public health and surveillance systems, to name some. Within USAID’s existing flagship implementation projects, Act | East led by RTI and Act | West led by FHI360, endemic countries and implementing partners frequently encounter these highlighted challenges in implementation. Increasingly, there are challenges in approaching post-elimination strategies, such as country-specific periodic surveillance and provision of NTD services after elimination/control has been reached (thereafter community-wide drug treatments have ended). ENDOR will support national governments, local research institutions, and local NGOs by addressing the following high level Focus Areas: 1. Fostering and convening a network of local and international research investigators, including young and mid-career researchers, and identifying and prioritizing NTD OR needs in a more diverse and equitable manner; 2. Defining and undertaking relevant coordinated research initiatives as prioritized by USAID and USAID NTD Program implementing partners to target the gaps and barriers highlighted by the WHO 2030 NTD Roadmap and the NTD community; 3. Improving the timeliness and quality of OR initiatives through issuance of subaward agreements under ENDOR directly to local and endemic country institutions in response to persistent and new challenges, and translating these into programmatic solutions to solve endemic country issues; and 4. Working collaboratively with the NTD donor community to ensure that support for research is equitable and appropriate to meet project needs.

Category: Health.

Applying now

This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.